Physician profile
Joseph Idicula
NPI 1497758106
$3,433.02
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $690 · 2020: $997 · 2021: $718 · 2022: $713 · 2023: $276 · 2024: $39.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $315.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $500.81 | 2019-2022 | |
| Medtronic, INC. | $425.67 | 2021-2022 | |
| Amarin Pharma, INC. | $402.27 | 2019-2022 | |
| Amgen INC. | $391.43 | 2019-2024 | Repatha |
| Astrazeneca Pharmaceuticals LP | $356.91 | 2019-2022 | |
| Abbott Laboratories | $225.93 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $209.31 | 2019-2022 | |
| Boston Scientific Corporation | $166.78 | 2021-2024 | Lux-Dx Insertable Cardiac Monitor, Varithena Administration Pack |
| Medtronic Vascular, INC. | $116.83 | 2019 | |
| Novartis Pharmaceuticals Corporation | $90.47 | 2019-2022 | |
| Pfizer INC. | $87.72 | 2019-2023 | |
| Arbor Pharmaceuticals, INC. | $64.29 | 2019-2021 | |
| Esperion Therapeutics, INC. | $58.13 | 2021-2023 | Nexletol |
| Kowa Pharmaceuticals America, INC. | $55.67 | 2019 | |
| Abiomed | $41.46 | 2022-2023 | Impella |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elutia, INC. | $33.96 | 2020 | |
| Novo Nordisk INC | $31.04 | 2021-2023 | Ozempic |
| E.R. Squibb & Sons, L.L.C. | $27.78 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.75 | 2021 | |
| Inari Medical, INC. | $19.36 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Edwards Lifesciences Corporation | $18.86 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $17.57 | 2023 | Inpefa |
| Braemar Manufacturing, LLC | $15.89 | 2019 | |
| Astellas Pharma US INC | $15.71 | 2020 | |
| Cardiovascular Systems INC. | $14.33 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $12.13 | 2019 | |
| Sanofi-Aventis U.S. LLC | $11.96 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Idicula listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.